Harbin Gloria Pharmaceuticals Co. Ltd. A | Cash Flow
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
230
456
713
728
305
129
Depreciation, Depletion & Amortization
68
103
151
164
183
194
Other Funds
-
295
148
130
225
455
Funds from Operations
297
589
967
1,042
688
725
Changes in Working Capital
175
95
258
2
29
442
Net Operating Cash Flow
472
684
709
1,044
659
1,167
Capital Expenditures
163
126
283
185
195
Sale of Fixed Assets & Businesses
1
1
2
45
10
Purchase/Sale of Investments
175
239
159
288
61
Net Investing Cash Flow
711
1,500
1,654
1,508
1,452
Cash Dividends Paid - Total
168
28
73
183
110
Issuance/Reduction of Debt, Net
25
780
1,219
724
851
Net Financing Cash Flow
193
1,047
997
410
516
Net Change in Cash
433
231
52
50
287
Free Cash Flow
309
558
426
859
465
Deferred Taxes & Investment Tax Credit
1
-
8
15
42
52
Net Assets from Acquisitions
416
1,614
1,118
1,154
1,000
Other Sources
42
-
-
75
76
Exchange Rate Effect
-
-
-
4
11
About Harbin Gloria Pharmaceuticals Co.
View Profile
